Interesting as seems to confirm we will struggle to create income from imyc or any of the other internal programs in the near term and instead our focus is back on the fpp delivery platform. I am actually glad to hear this put so clearly. I fully agree the fpp platform should at least present some form of pharma deal if it is truly all it is claimed to be. Still feels like we just need one new deal with the "new pyc" to show we have progressed from the old chopping and changing pyc into a new highly focussed entity that knows what it is and where it is heading.
Ann: Chairman's Address - 2017 Annual General Meeting, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |